- Dylan Van Haaften
- Edward Hall
- Eric Yoo
- Ingird Gafanhão
- Khalid Deojee
- Olga Smolentseva
HEALTHCARE update Q3 Our take on the healthcare market
HEALTHCARE update Q3 Our take on the healthcare marketBiotech outperforming supported by solid fundamentals amid a tough macro environment
Biotech outperforming the general market and other healthcare segments
Positive readouts led to sustained share price moves indicating good fundamentals
M&A is not breaking any records, but pharma continues to target commercial-stage companies
Public capital raises picked up in the summer on the back of data but overall volume down
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.